UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

December 31, 2014

Date of Report (date of earliest event reported)

 

Fuse Medical, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-10093

 

59-1224913

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

4770 Bryant Irvin Court, Suite 300 , Fort Worth, TX 76107

(Address of principal executive offices) (Zip Code)

 

(817) 439-7025

Registrant's telephone number, including area code

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below):

 

¨

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 

Item 1.01 Entry Into a Material Definitive Agreement.

 

Debt Assumption and Release Agreements

 

On December 31, 2014, Fuse Medical, Inc. (the “ Company ”), and Fuse Medical, LLC, a wholly-owned subsidiary of the Company (" Fuse LLC "), entered into three separate Debt Assumption and Release Agreements (the “ Release Agreements ”) with WHIG Enterprises, LLC (" WHIG ") and World Health Industries, Inc. ("WHI") (WHI collectively with WHIG, " WHI Group "), Cooks Bridge, LLC (" CB "), and JAR Financing, LLC (" JAR "). Pursuant to the terms of the Release Agreements, as a result of the winding down of the business activities of Fuse LLC, the Company agreed to assume all of the outstanding debt owed by Fuse LLC to WHI Group in the principal amount of $727,776.48 plus $26,245.93 of accrued interest, CB in the principal amount of $466,933.27 plus $18,328.44 of accrued interest, and JAR in the principal amount of $317,305.10 plus $13,318.25 of accrued interest (collectively, the " Outstanding Debt "). In consideration for the assumption of the Outstanding Debt, WHI Group, CB, and JAR all agreed to release Fuse LLC from any claims related to the Outstanding Debt. Each of the parties has made customary representations and warranties in the Release Agreements.

 

The Release Agreements are attached as Exhibits 10.1, 10.2, and 10.3 to this Form 8-K.

 

Debt Conversion Agreements

 

Also on December 31, 2014, the Company entered into three separate Debt Conversion Agreements (" Conversion Agreements ") with WHI Group, CB, and JAR. Pursuant to the terms of the Conversion Agreements, WHI Group, CB, and JAR and the Company agreed to convert the existing Outstanding Debt into unregistered shares of the Company's common stock at a conversion price of $1.04 per share. Pursuant to the terms of the Conversion Agreements, WHIG, on behalf of WHI Group, received 725,022 shares of the Company's common stock, CB received 466,598 shares of the Company's common stock, and JAR received 317,908 shares of the Company's common stock. Each of the parties has made customary representations and warranties in the Conversion Agreements, including, but not limited to, representations on investment intent and financial sophistication.

 

The Conversion Agreements are attached as Exhibits 10.4, 10.5, and 10.6 to this Form 8-K.

 

Management and Ownership of CB

 

CB is managed by Jonathan Brown, a director of the Company, and Rusty Shelton, the Chief Development Officer of the Company.

 

Twelve Global, LLC, a member of CB, owns 30.1% of the Company and Jonathan Brown, a director of the Company, is sole member of Twelve Global, LLC.

 

Resurge Hospitals, Inc., a member of CB, owns 13.5% of the Company. Rusty Shelton, the Chief Development Officer of the Company, is the sole stockholder of Resurge Hospitals, Inc.

 

CCEP Holdings LLC, a member of CB, owns 16.2% of the Company. Dr. Chris Pratt, the Chief Medical Director of the Company, is the sole member of CCEP Holdings LLC.

 

TJAL Holdings, LLC, a member of CB, owns 4.5% of the Company. Dr. Randall Dei is the sole member of TJAL Holdings, LLC and is the Medical Director of Podiatry of the Company.

 

Coastal IP, LLC, a member of CB, owns 4.5% of the Company. Dr. Erik Nilssen is the sole member of Coastal IP, LLC and is a Medical Director of the Company.

 

Lion Share LLC, a member of CB, owns 1.8% of the Company. Dr. Steve Corey is the sole member of Lion Share LLC and is a Medical Director of the Company.

 

Robert Donehew, the former Chief Executive Officer of the Company, is the sole member of Trebor Opportunities LLC. Trebor Opportunities LLC is a member of CB. Mr. Donehew owns 2.9% of the Company.

 

 
2

   

Management and Ownership of JAR

 

JAR is managed by Alan Meeker, the Chief Executive Officer and President of the Company, Jonathan Brown, a director of the Company, and Rusty Shelton, the Chief Development Officer of the Company. Mr. Meeker is the sole member of Axis Global, LLC, which owns 13.5% of the Company. Mr. Meeker is the manager of Crestview Farm Aiken, LLC, which owns a membership interest in JAR. Mr. Meeker does not own a membership interest in JAR.

 

Twelve Global, LLC is a member of JAR and owns 30.1% of the Company. Jonathan Brown, a director of the Company, is the sole member of Twelve Global, LLC.

 

Resurge Hospitals, Inc., a member of JAR, owns 13.5% of the Company. Rusty Shelton, the Chief Development Officer of the Company, is the sole stockholder of Resurge Hospitals, Inc.

 

Management and Ownership of WHIG

 

ShennaCo Investment Corporation Inc. (" ShennaCo ") owns a 15% interest in WHIG. Alan Meeker, the Chief Executive Officer and President of the Company, is the President of ShennaCo. The David Alan Meeker Family Irrevocable Trust (" DAMFIT ") is the sole shareholder in ShennaCo. Mr. Meeker does not serve as a trustee nor is he a beneficiary of DAMFIT.

 

Item 3.02 Unregistered Sales of Equity Securities.

 

On December 31, 2014, pursuant to the Conversion Agreements, the Company converted the Outstanding Debt of accredited investors, WHIG, WHI, JAR, and CB, into shares of the Company's common stock at a conversion rate of $1.04 per share. The Company issued: WHIG 725,022 shares of the Company's common stock; CB 466,598 shares of the Company's common stock; and JAR 317,908 shares of the Company's common stock. These issuances were all made to accredited investors pursuant to the registration exemptions of the Securities Act afforded under Section 4(2) thereunder and Rule 506 of Regulation D of the Securities Act.

 

 
3

  

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits:

 

Exhibit No.

 

Description

10.1

 

Debt Assumption and Release Agreement dated December 31, 2014, by and among World Health Industries, Inc., WHIG, LLC, Fuse Medical, LLC, and Fuse Medical, Inc.

10.2

 

Debt Assumption and Release Agreement dated December 31, 2014, by and among Cooks Bridge, LLC, Fuse Medical, Inc., and Fuse Medical, LLC.

10.3

 

Debt Assumption and Release Agreement dated December 31, 2014, by and among JAR Financing, LLC, Fuse Medical, Inc., and Fuse Medical, LLC.

10.4

 

Debt Conversion Agreement dated December 31, 2014, by and among World Health Industries, Inc., WHIG, LLC, and Fuse Medical, Inc.

10.5

 

Debt Conversion Agreement dated December 31, 2014, by and between Cooks Bridge, LLC, and Fuse Medical, Inc.

10.6

 

Debt Conversion Agreement dated December 31, 2014, by and between JAR Financing, LLC and Fuse Medical, Inc.

 

 
4

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

Fuse Medical, Inc.

(Registrant)

 
       

Date: January 6, 2015

By:

/s/ D. Alan Meeker

 
 

Name:

D. Alan Meeker

 
 

Title:

Chief Executive Officer

 

 

 
5

 

EXHIBIT INDEX

 

Exhibit No.

 

Description

10.1

 

Debt Assumption and Release Agreement dated December 31, 2014, by and among World Health Industries, Inc., WHIG, LLC, Fuse Medical, LLC, and Fuse Medical, Inc.

10.2

 

Debt Assumption and Release Agreement dated December 31, 2014, by and among Cooks Bridge, LLC, Fuse Medical, Inc., and Fuse Medical, LLC.

10.3

 

Debt Assumption and Release Agreement dated December 31, 2014, by and among JAR Financing, LLC, Fuse Medical, Inc., and Fuse Medical, LLC.

10.4

 

Debt Conversion Agreement dated December 31, 2014, by and among World Health Industries, Inc., WHIG, LLC, and Fuse Medical, Inc.

10.5

 

Debt Conversion Agreement dated December 31, 2014, by and between Cooks Bridge, LLC, and Fuse Medical, Inc.

10.6

 

Debt Conversion Agreement dated December 31, 2014, by and between JAR Financing, LLC and Fuse Medical, Inc.

 

 

 

6


EXHIBIT 10.1

 

EXECUTION VERSION

 

DEBT ASSUMPTION AND RELEASE AGREEMENT

 

This DEBT ASSUMPTION AND RELEASE AGREEMENT (this “ Agreement ”) is made as of the 31st day of December, 2014 (the “ Assignment Date ”), by and between Fuse Medical, LLC, a Delaware limited liability company (“ Transferor ”), World Health Industries, Inc., a Mississippi corporation, and WHIG Enterprises, LLC (aka WHIG, LLC), a Florida limited liability company (collectively, “ Releasing Party ”), and Fuse Medical, Inc., a Delaware corporation (“ Transferee ”).

 

RECITALS

 

A. As of the date of this Agreement, Transferor owes Releasing Party the amount outstanding set forth on Schedule A  attached hereto (the “ Outstanding Debt ”).

 

B. As a result of its efforts to wind up its business, Transferor wishes to assign all of its rights and obligations with respect to the Outstanding Debt to its parent, Transferee, and Transferee wishes to accept such rights and assume such obligations, all as set forth below (the “ Assignment ”).

 

C. Immediately after the Assignment, in further consideration for Transferor permitting such Assignment, Transferee will issue 725,022 shares of Transferee’s common stock (the “ Shares ”) pursuant to a Debt Conversion Agreement, dated as of the date hereof, by and between Releasing Party and Transferee (the “ Conversion Agreement ”) to retire, in full, the Outstanding Debt.

 

NOW, THEREFORE, in consideration of the recitals and the mutual covenants and agreements hereinafter set forth, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

 

1. Assignment.

 

(a) Transferor hereby irrevocably sells and assigns to Transferee, effective as of the Assignment Date, all of its liabilities, obligations and commitments with respect to the Outstanding Debt. On and after the Assignment Date, Transferee shall have the same rights, duties and obligations as Transferor had, as a borrower, and Transferor shall be irrevocably released from its obligations, liabilities and responsibilities with respect to the Outstanding Debt. All payments of interest, fees and other amounts or past due monies owed by Transferor (including but not limited to legal expenses incurred by Transferor) in respect of the Outstanding Debt shall be paid to Releasing Party by Transferee.

 

(b) Except as set forth in Section 3(a), Transferor does not make any representation or warranty of any kind to Releasing Party and, in particular, the financial condition or creditworthiness of Transferee or Transferor.

 

2. Assumption and Agreement to be Bound. Transferee hereby accepts, effective as of the Assignment Date, the assignment of all of Transferor’s liabilities, obligations and commitments with respect to the Outstanding Debt, and assumes and agrees to perform fully all of the obligations of Transferor with respect to the Outstanding Debt.

 

 
1

 

3. Representations and Warranties.

 

(a) Transferee and Transferor hereby represent and warrant to one another, as applicable that as of the Assignment Date:

 

(i) Transferor is duly authorized and qualified to sell and assign the Outstanding Debt and transfer or assign the duties and obligations with respect to the Outstanding Debt. Transferee is duly authorized and qualified to purchase and accept the assignment of the Outstanding Debt and assume the duties and obligations with respect to the Outstanding Debt.

 

(ii) This Agreement is valid and binding on Transferee and Transferor and enforceable against Transferee and Transferor in accordance with its terms.

 

(b) Releasing Party hereby represents and warrants to Transferor and Transferee that, as of the Assignment Date, the Outstanding Debt constitutes all of the liabilities owed to it by Transferor immediately prior to the execution of this Agreement.

 

4. Conditions. This Agreement is conditioned and contingent upon Releasing Party and Transferee entering into the Conversion Agreement.

 

5. Release by Releasing Parties. Execution of this Agreement will automatically, by operation of this Agreement and without any further action on the part of the parties hereto, effect a release and discharge by Releasing Party and its affiliates and past, present and future officers, directors, shareholders, employees, agents, successors and assigns from all manner of action, cause and causes of action, suits, debts, sums of money, accounts, covenants, controversies, agreements, promises, damages, judgments, executions, costs, expenses, rights, claims or demands whatsoever, at law or in equity, existing at the date thereof, at any time before the date thereof, or thereafter arising, both anticipated and unanticipated, known and unknown, contingent and non-contingent, liquidated and non-liquidated, that Releasing Party has had, now has, then has or may have against Transferor or its affiliates or past, present or future officers, directors, shareholders, employees, agents, successors or assigns by reason of any cause or thing, arising or to arise, out of the Outstanding Debt and any and all agreements, purchase orders, invoices or other arrangements, written or oral, with respect to the relationship between Transferor and Releasing Party and concerning the Outstanding Debt. For purposes herein, “Releasing Party” shall be deemed to include any affiliate of the Releasing Party.

 

6. Waiver. Releasing Party hereby irrevocably waives its rights under any applicable statute, rule, regulation, legal principle or legal doctrine that provides that a general release does not extend to claims which a releasing party does not know or suspect to exist in its favor at the time of executing such release, which if known by Releasing Party, would have materially affected its settlement with the released party.

 

7. GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY THE LAW OF THE STATE OF DELAWARE (REGARDLESS OF THE LAWS THAT MIGHT OTHERWISE GOVERN UNDER APPLICABLE DELAWARE PRINCIPLES OF CONFLICTS OF LAW) AS TO ALL MATTERS, INCLUDING, WITHOUT LIMITATION, MATTERS OF VALIDITY, CONSTRUCTION, EFFECT, PERFORMANCE AND REMEDIES.

 

 
2

 

8. Miscellaneous.

 

(a) Headings . Article and Section headings have been inserted in this Agreement as a matter of convenience for reference only and it is agreed that such article and section headings are not a part of this Agreement and shall not be used in the interpretation of any provision of this Agreement.

 

(b) Entire Agreement . This Agreement embodies the entire agreement and understanding between the parties hereto and supersedes all prior agreements and understandings between the parties relating to the subject matter hereof.

 

(c) Further Assurances . Each of the parties hereby agree to execute and deliver such other instruments, and take such other action, as any party may reasonably request in furtherance of the transactions contemplated by this Agreement.

 

(d) Successors and Assigns . This Agreement shall be binding upon and inure to the benefit of the parties hereto, their respective successors and assigns. This Agreement may not be assigned without the consent of the other parties hereto.

 

(e) Counterparts . This Agreement may be executed by facsimile or other electronic signature, in counterparts, which, when taken together, shall constitute one and the same original.

 

[SIGNATURE PAGES FOLLOW]

 

 
3

 

EXECUTION VERSION

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first above written.

 

  TRANSFEROR :  
       
FUSE MEDICAL, LLC, a Delaware limited liability company
   
By: /s/ Alan Meeker  
  Name: Alan Meeker  
  Title: Manager  
       
   

TRANSFEREE

 

FUSE MEDICAL, LLC, a Delaware limited liability company 

 
By: /s/ Alan Meeker
Name: Alan Meeker
Title: Chief Executive Officer
 

RELEASING PARTY :

 

WORLD HEALTH INDUSTRIES, INC., a Mississippi corporation

 
By: /s/ Mitchell Chad Barrett
Name: Mitchell Chad Barrett
Title: CEO
   
    

WHIG Enterprises, LLC, a Mississippi limited liability company

 
By: /s/ Mitchell Chad Barrett
Name: Mitchell Chad Barrett
Title: Manager

   

[SIGNATURE PAGE TO DEBT ASSUMPTION AND RELEASE AGREEMENT]

 

 
4

 

EXECUTION VERSION

 

Schedule A

 

OUTSTANDING DEBT SCHEDULE

 

Note

 

Maturity Date

  Amount  

Promissory Note dated February 6, 2014, payable to World Health Industries, Inc. and WHIG, LLC from Fuse Medical, LLC

 

2/6/2016

 

$

116,777.24

 

Promissory Note dated May 23, 2014, payable to World Health Industries, Inc. and WHIG, LLC from Fuse Medical, LLC

 

5/23/2016

 

$

479,975.58

 

Promissory Note dated January 14, 2014, payable to World Health Industries, Inc. and WHIG, LLC from Fuse Medical, LLC

 

1/14/2016

 

$

131,023.66

 

TOTAL:

 

 

 

$

727,776.48

 

 

 

5


EXHIBIT 10.2

 

EXECUTION VERSION

 

DEBT ASSUMPTION AND RELEASE AGREEMENT

 

This DEBT ASSUMPTION AND RELEASE AGREEMENT (this “ Agreement ”) is made as of the 31st day of December, 2014 (the “ Assignment Date ”), by and between Fuse Medical, LLC, a Delaware limited liability company (“ Transferor ”), Cooks Bridge, LLC, a Delaware limited liability company (“ Releasing Party ”), and Fuse Medical, Inc., a Delaware corporation (“ Transferee ”).

 

RECITALS

 

A. As of the date of this Agreement, Transferor owes Releasing Party the amount outstanding set forth on Schedule A  attached hereto (the “ Outstanding Debt ”).

 

B. As a result of its efforts to wind up its business, Transferor wishes to assign all of its rights and obligations with respect to the Outstanding Debt to its parent, Transferee, and Transferee wishes to accept such rights and assume such obligations, all as set forth below (the “ Assignment ”).

 

C. Immediately after the Assignment, in further consideration for Transferor permitting such Assignment, Transferee will issue 466,598 shares of Transferee’s common stock (the “ Shares ”) pursuant to a Debt Conversion Agreement, dated as of the date hereof, by and between Releasing Party and Transferee (the “ Conversion Agreement ”) to retire, in full, the Outstanding Debt.

 

NOW, THEREFORE, in consideration of the recitals and the mutual covenants and agreements hereinafter set forth, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

 

1. Assignment.

 

(a) Transferor hereby irrevocably sells and assigns to Transferee, effective as of the Assignment Date, all of its liabilities, obligations and commitments with respect to the Outstanding Debt. On and after the Assignment Date, Transferee shall have the same rights, duties and obligations as Transferor had, as a borrower, and Transferor shall be irrevocably released from its obligations, liabilities and responsibilities with respect to the Outstanding Debt. All payments of interest, fees and other amounts or past due monies owed by Transferor (including but not limited to legal expenses incurred by Transferor) in respect of the Outstanding Debt shall be paid to Releasing Party by Transferee.

 

(b) Except as set forth in Section 3(a), Transferor does not make any representation or warranty of any kind to Releasing Party and, in particular, the financial condition or creditworthiness of Transferee or Transferor.

 

2. Assumption and Agreement to be Bound. Transferee hereby accepts, effective as of the Assignment Date, the assignment of all of Transferor’s liabilities, obligations and commitments with respect to the Outstanding Debt, and assumes and agrees to perform fully all of the obligations of Transferor with respect to the Outstanding Debt.

 

 
1

 

3. Representations and Warranties.

 

(a) Transferee and Transferor hereby represent and warrant to one another, as applicable, that as of the Assignment Date:

 

(i) Transferor is duly authorized and qualified to sell and assign the Outstanding Debt and transfer or assign the duties and obligations with respect to the Outstanding Debt. Transferee is duly authorized and qualified to purchase and accept the assignment of the Outstanding Debt and assume the duties and obligations with respect to the Outstanding Debt.

 

(ii) This Agreement is valid and binding on Transferee and Transferor and enforceable against Transferee and Transferor in accordance with its terms.

 

(b) Releasing Party hereby represents and warrants to Transferor and Transferee that, as of the Assignment Date, the Outstanding Debt constitutes all of the liabilities owed to it by Transferor immediately prior to the execution of this Agreement.

 

4. Conditions. This Agreement is conditioned and contingent upon Releasing Party and Transferee entering into the Conversion Agreement.

 

5. Release by Releasing Parties. Execution of this Agreement will automatically, by operation of this Agreement and without any further action on the part of the parties hereto, effect a release and discharge by Releasing Party and its affiliates and past, present and future officers, directors, shareholders, employees, agents, successors and assigns from all manner of action, cause and causes of action, suits, debts, sums of money, accounts, covenants, controversies, agreements, promises, damages, judgments, executions, costs, expenses, rights, claims or demands whatsoever, at law or in equity, existing at the date thereof, at any time before the date thereof, or thereafter arising, both anticipated and unanticipated, known and unknown, contingent and non-contingent, liquidated and non-liquidated, that Releasing Party has had, now has, then has or may have against Transferor or its affiliates or past, present or future officers, directors, shareholders, employees, agents, successors or assigns by reason of any cause or thing, arising or to arise, out of the Outstanding Debt and any and all agreements, purchase orders, invoices or other arrangements, written or oral, with respect to the relationship between Transferor and Releasing Party and concerning the Outstanding Debt. For purposes herein, “Releasing Party” shall be deemed to include any affiliate of the Releasing Party.

 

6. Waiver. Releasing Party hereby irrevocably waives its rights under any applicable statute, rule, regulation, legal principle or legal doctrine that provides that a general release does not extend to claims which a releasing party does not know or suspect to exist in its favor at the time of executing such release, which if known by Releasing Party, would have materially affected its settlement with the released party.

 

7. GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY THE LAW OF THE STATE OF DELAWARE (REGARDLESS OF THE LAWS THAT MIGHT OTHERWISE GOVERN UNDER APPLICABLE DELAWARE PRINCIPLES OF CONFLICTS OF LAW) AS TO ALL MATTERS, INCLUDING, WITHOUT LIMITATION, MATTERS OF VALIDITY, CONSTRUCTION, EFFECT, PERFORMANCE AND REMEDIES.

 

 
2

 

8. Miscellaneous.

 

(a) Headings . Article and Section headings have been inserted in this Agreement as a matter of convenience for reference only and it is agreed that such article and section headings are not a part of this Agreement and shall not be used in the interpretation of any provision of this Agreement.

 

(b) Entire Agreement . This Agreement embodies the entire agreement and understanding between the parties hereto and supersedes all prior agreements and understandings between the parties relating to the subject matter hereof.

 

(c) Further Assurances . Each of the parties hereby agree to execute and deliver such other instruments, and take such other action, as any party may reasonably request in furtherance of the transactions contemplated by this Agreement.

 

(d) Successors and Assigns . This Agreement shall be binding upon and inure to the benefit of the parties hereto, their respective successors and assigns. This Agreement may not be assigned without the consent of the other parties hereto.

 

(e) Counterparts . This Agreement may be executed by facsimile or other electronic signature, in counterparts, which, when taken together, shall constitute one and the same original.

 

[SIGNATURE PAGES FOLLOW]

 

 
3

 

EXECUTION VERSION

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first above written.

 

  TRANSFEROR :  
       

FUSE MEDICAL, LLC, a Delaware limited liability company

 
By: /s/ Alan Meeker  
  Name: Alan Meeker  
  Title: Manager  
       
    

TRANSFEREE :

 

FUSE MEDICAL, INC., a Delaware corporation

 
By: /s/ Alan Meeker
Name: Alan Meeker
Title: Chief Executive Officer
 
     

RELEASING PARTY :

 

COOKS BRIDGE, LLC, a Delaware limited liability company

 
By: /s/ Rusty Shelton
Name: Rusty Shelton
Title: Manager

  

[SIGNATURE PAGE TO DEBT ASSUMPTION AND RELEASE AGREEMENT]

 

 
4

 

EXECUTION VERSION

 

Schedule A

 

OUTSTANDING DEBT SCHEDULE

 

Note

 

Maturity Date

  Amount  

Promissory Note dated March 4, 2014, payable to Cooks Bridge, LLC from Fuse Medical, LLC

 

3/4/2016

 

$

87,670.49

 

Promissory Note dated January 15, 2014, payable to Cooks Bridge, LLC from Fuse Medical, LLC

 

1/14/2016

   

131,023.65

 

Promissory Note dated June 16, 2014, payable to Cooks Bridge, LLC from Fuse Medical, LLC

 

6/16/2016

   

56,461.88

 

Promissory Note dated February 1, 2014, payable to Cooks Bridge, LLC from Fuse Medical, LLC

 

1/31/2016

   

116,777.25

 

Promissory Note dated May 8, 2014, payable to Cooks Bridge, LLC from Fuse Medical, LLC

 

5/8/2016

   

75,000.00

 

TOTAL:

 

 

 

$

466,933.27

 

 

 

5


EXHIBIT 10.3

 

EXECUTION VERSION

 

DEBT ASSUMPTION AND RELEASE AGREEMENT

 

This DEBT ASSUMPTION AND RELEASE AGREEMENT (this “ Agreement ”) is made as of the 31st day of December, 2014 (the “ Assignment Date ”), by and between Fuse Medical, LLC, a Delaware limited liability company (“ Transferor ”), JAR Financing LLC, a Delaware limited liability company (“ Releasing Party ”), and Fuse Medical, Inc., a Delaware corporation (“ Transferee ”).

 

RECITALS

 

A. As of the date of this Agreement, Transferor owes Releasing Party the amount outstanding set forth on Schedule A  attached hereto (the “ Outstanding Debt ”).

 

B. As a result of its efforts to wind up its business, Transferor wishes to assign all of its rights and obligations with respect to the Outstanding Debt to its parent, Transferee, and Transferee wishes to accept such rights and assume such obligations, all as set forth below (the “ Assignment ”).

 

C. Immediately after the Assignment, in further consideration for Transferor permitting such Assignment, Transferee will issue 317,908 shares of Transferee’s common stock (the “ Shares ”) pursuant to a Debt Conversion Agreement, dated as of the date hereof, by and between Releasing Party and Transferee (the “ Conversion Agreement ”) to retire, in full, the Outstanding Debt.

 

NOW, THEREFORE, in consideration of the recitals and the mutual covenants and agreements hereinafter set forth, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

 

1. Assignment.

 

(a) Transferor hereby irrevocably sells and assigns to Transferee, effective as of the Assignment Date, all of its liabilities, obligations and commitments with respect to the Outstanding Debt. On and after the Assignment Date, Transferee shall have the same rights, duties and obligations as Transferor had, as a borrower, and Transferor shall be irrevocably released from its obligations, liabilities and responsibilities with respect to the Outstanding Debt. All payments of interest, fees and other amounts or past due monies owed by Transferor (including but not limited to legal expenses incurred by Transferor) in respect of the Outstanding Debt shall be paid to Releasing Party by Transferee.

 

(b) Except as set forth in Section 3(a), Transferor does not make any representation or warranty of any kind to Releasing Party and, in particular, the financial condition or creditworthiness of Transferee or Transferor.

 

2. Assumption and Agreement to be Bound. Transferee hereby accepts, effective as of the Assignment Date, the assignment of all of Transferor’s liabilities, obligations and commitments with respect to the Outstanding Debt, and assumes and agrees to perform fully all of the obligations of Transferor with respect to the Outstanding Debt.

 

 
1

 

3. Representations and Warranties.

 

(a) Transferee and Transferor hereby represent and warrant to one another, as applicable, that as of the Assignment Date:

 

(i) Transferor is duly authorized and qualified to sell and assign the Outstanding Debt and transfer or assign the duties and obligations with respect to the Outstanding Debt. Transferee is duly authorized and qualified to purchase and accept the assignment of the Outstanding Debt and assume the duties and obligations with respect to the Outstanding Debt.

 

(ii) This Agreement is valid and binding on Transferee and Transferor and enforceable against Transferee and Transferor in accordance with its terms.

 

(b) Releasing Party hereby represents and warrants to Transferor and Transferee that, as of the Assignment Date, the Outstanding Debt constitutes all of the liabilities owed to it by Transferor immediately prior to the execution of this Agreement.

 

4. Conditions. This Agreement is conditioned and contingent upon Releasing Party and Transferee entering into the Conversion Agreement.

 

5. Release by Releasing Parties. Execution of this Agreement will automatically, by operation of this Agreement and without any further action on the part of the parties hereto, effect a release and discharge by Releasing Party and its affiliates and past, present and future officers, directors, shareholders, employees, agents, successors and assigns from all manner of action, cause and causes of action, suits, debts, sums of money, accounts, covenants, controversies, agreements, promises, damages, judgments, executions, costs, expenses, rights, claims or demands whatsoever, at law or in equity, existing at the date thereof, at any time before the date thereof, or thereafter arising, both anticipated and unanticipated, known and unknown, contingent and non-contingent, liquidated and non-liquidated, that Releasing Party has had, now has, then has or may have against Transferor or its affiliates or past, present or future officers, directors, shareholders, employees, agents, successors or assigns by reason of any cause or thing, arising or to arise, out of the Outstanding Debt and any and all agreements, purchase orders, invoices or other arrangements, written or oral, with respect to the relationship between Transferor and Releasing Party and concerning the Outstanding Debt. For purposes herein, “Releasing Party” shall be deemed to include any affiliate of the Releasing Party.

 

6. Waiver. Releasing Party hereby irrevocably waives its rights under any applicable statute, rule, regulation, legal principle or legal doctrine that provides that a general release does not extend to claims which a releasing party does not know or suspect to exist in its favor at the time of executing such release, which if known by Releasing Party, would have materially affected its settlement with the released party.

 

7. GOVERNING LAW. THIS AGREEMENT SHALL BE GOVERNED BY THE LAW OF THE STATE OF DELAWARE (REGARDLESS OF THE LAWS THAT MIGHT OTHERWISE GOVERN UNDER APPLICABLE DELAWARE PRINCIPLES OF CONFLICTS OF LAW) AS TO ALL MATTERS, INCLUDING, WITHOUT LIMITATION, MATTERS OF VALIDITY, CONSTRUCTION, EFFECT, PERFORMANCE AND REMEDIES.

 

 
2

 

8. Miscellaneous.

 

(a) Headings . Article and Section headings have been inserted in this Agreement as a matter of convenience for reference only and it is agreed that such article and section headings are not a part of this Agreement and shall not be used in the interpretation of any provision of this Agreement.

 

(b) Entire Agreement . This Agreement embodies the entire agreement and understanding between the parties hereto and supersedes all prior agreements and understandings between the parties relating to the subject matter hereof.

 

(c) Further Assurances . Each of the parties hereby agree to execute and deliver such other instruments, and take such other action, as any party may reasonably request in furtherance of the transactions contemplated by this Agreement.

 

(d) Successors and Assigns . This Agreement shall be binding upon and inure to the benefit of the parties hereto, their respective successors and assigns. This Agreement may not be assigned without the consent of the other parties hereto.

 

(e) Counterparts . This Agreement may be executed by facsimile or other electronic signature, in counterparts, which, when taken together, shall constitute one and the same original.

 

[SIGNATURE PAGES FOLLOW]

 

 
3

 

EXECUTION VERSION

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be executed as of the date first above written.

 

 

  TRANSFEROR  
 

FUSE MEDICAL, LLC, a Delaware limited liability company

 
By: /s/ Alan Meeker  
  Name: Alan Meeker  
  Title: Manager  

 

  TRANSFEREE :  
     
  FUSE MEDICAL, INC., a Delaware corporation  
  By: /s/ Alan Meeker  
  Name: Alan Meeker  
  Title: Chief Executive Officer  

RELEASING PARTY :

 

JAR Financing LLC, a Delaware limited liability company

 
By: /s/ Rusty Shelton
Name: Rusty Shelton
Title: Manager

 

[SIGNATURE PAGE TO DEBT ASSUMPTION AND RELEASE AGREEMENT]

 

 
4

 

EXECUTION VERSION

 

Schedule A

 

OUTSTANDING DEBT SCHEDULE

 

Note

 

Maturity Date

  Amount  

Promissory Note dated December 31, 2013, payable to JAR, LLC from Fuse Medical, LLC

 

12/30/2015

 

$

60,000.00

 

Promissory Note dated March 4, 2014, payable to JAR Financing, LLC from Fuse Medical, LLC

 

3/4/2016

 

$

63,769.63

 

Promissory Note dated February 10, 2014, payable to JAR, LLC from Fuse Medical, LLC

 

2/9/2016

 

$

193,535.47

 

TOTAL:

 

 

 

$

317,305.10

 

 

 

5


 

EXHIBIT 10.4

 

EXECUTION VERSION

 

DEBT CONVERSION AGREEMENT

 

THIS DEBT CONVERSION AGREEMENT (this “ Agreement ”) is made and entered into as of December 31, 2014, by and between Fuse Medical, Inc., a Delaware corporation (the “ Company ”), and World Health Industries, Inc., a Mississippi corporation and WHIG Enterprises, LLC (aka WHIG, LLC), a Florida limited liability company (collectively, “ Lender ”).

 

RECITALS

 

A. The Company and Lender are parties to a Debt Assumption and Release Agreement, dated as of the date hereof (the “ Debt Assumption Agreement ”), pursuant to which the Company assumed $727,776.48 of principal and $26,245.93 of accrued interest owed to Lender (the “ Outstanding Debt ”) and the parties agreed to enter into this Agreement to retire the Outstanding Debt.

 

B. The parties to this Agreement have agreed to convert the Outstanding Debt into shares of the Company’s common stock as herein described, according to the terms and subject to the conditions hereinafter set forth.

 

NOW, THEREFORE, in consideration for the mutual promises and covenants set forth herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows:

 

1.  Debt Conversion.

 

(a) Lender agrees, subject to the conditions set forth herein, to convert the full amount of the Outstanding Debt into 725,022 shares of the Company’s common stock (the “ Conversion Shares ”) at a conversion price of $1.04 per share (the “ Conversion Price ”).

 

(b) Subject to the terms and conditions of this Agreement, the consummation of the transaction contemplated by this Agreement shall take place at a closing (the “ Closing ”) to be held at 10:00 a.m., local time, on date set by the Company, but no later than December 31, 2014, at the offices of the Company, or at such other time, date or place as the parties may agree upon in writing. At the Closing, Lender shall deliver a certificate of an officer acknowledging the retirement of the Outstanding Debt and the Company shall deliver a certificate evidencing ownership of the Conversion Shares and which shall include the restrictive legend.

 

2.  Legends. All certificates representing any shares subject to the provisions of this Agreement shall have endorsed thereon the following legends:

 

(a)  “THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES. THE SALE IS MADE IN ACCORDANCE WITH RULE 144 UNDER THE ACT, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE SECURITIES REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT.”

 

 
1

 

EXECUTION VERSION

 

(b) Any other legend required to be placed thereon under applicable state securities laws.

 

3.  Representations and Warranties. In connection with the proposed conversion, Lender hereby agrees, represents and warrants as follows:

 

(a) Lender has full legal power and capacity to execute and deliver this Agreement and to perform its obligations hereunder. All acts required to be taken by Lender to enter into this Agreement and to carry out the transaction contemplated hereby have been properly taken; and this Agreement constitutes a legal, valid and binding obligation of Lender enforceable in accordance with its terms.

 

(b) Lender is receiving the Conversion Shares solely for Lender’s own account for investment and not with a view to, or for resale in connection with, any distribution thereof within the meaning of the Securities Act. Lender has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Company’s securities.

 

(c) Lender has been given an opportunity to ask questions and receive answers from the officers and directors of the Company and to obtain additional information from the Company. Lender realizes that acceptance of the Conversion Shares at the Conversion Price is an investment in the Company, which is a highly speculative investment, and Lender is able, without impairing Lender’s financial condition, to hold the Conversion Shares for an indefinite period of time and to suffer a complete loss of Lender’s investment.

 

(d) Lender is relying solely on the representations and warranties contained herein in making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, and no oral representations or warranties of any kind have been made by the Company or its officers, directors, employees or agents to Lender.

 

(e) The Company has disclosed to Lender that:

 

(i) The Conversion Shares have not been registered under the Securities Act and the Conversion Shares must be held indefinitely unless a transfer is subsequently registered under the Securities Act, or an exemption from such registration is available, and that the Company is under no obligation to register the Conversion Shares;

 

(ii) The Company will make a notation in its records of the aforementioned restrictions on transfer and legends.

 

(f) Lender has sought such independent legal, tax and accounting advice and counsel as it has deemed necessary and appropriate and Lender is relying on the advice and counsel of his own legal, tax and accounting advisors.

 

 
2

 

EXECUTION VERSION

 

(g) Without in any way limiting Lender’s representations and warranties set forth above, Lender further agrees that Lender shall in no event make any disposition of all or any portion of the Conversion Shares which Lender is acquiring unless and until:

 

(i) There is then in effect a registration statement under the Securities Act (a “ Registration Statement ”) covering such proposed disposition and such disposition is made in accordance with said Registration Statement; or

 

(ii) Lender shall have notified the Company of the proposed disposition and the Company agrees that such disposition is exempt from the registration requirements of applicable state and federal securities laws.

 

4.  Transfers in Violation of Agreement. The Company shall not be required to (i) transfer on its books any Conversion Shares of the Company which shall have been sold or transferred in violation of any of the provisions set forth in this Agreement, or (ii) treat as owner of such shares or to accord the right to vote as such owner or to pay dividends to any transferee to whom such shares shall have been so transferred.

 

5.  Conditions.

 

(a) The obligations of the Company to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment of the following conditions:

 

(i) The representations and warranties of Lender set forth in Section 3  hereof shall be true and correct on and as of the Closing date.

 

(ii) All proceedings to be taken by Lender in connection with the consummation of the transactions contemplated by this Agreement shall have been duly and validly taken and all necessary consents, approvals or authorizations of any governmental or regulatory authority or other third party required to be obtained by the Company or Lender shall have been obtained in form and substance reasonably satisfactory to the Company.

 

(iii) Lender has delivered to the Company a certificate acknowledging the conversion of the Outstanding Debt and that there are no other obligations of the Company to Lender.

 

(b) The obligations of Lender to consummate the transaction contemplated by this Agreement shall be subject to the fulfillment of the following conditions:

 

(i) The representations and warranties of the Company set forth herein shall be true and correct on and as of the Closing date.

 

(ii) All proceedings, corporate or otherwise, to be taken by the Company in connection with the consummation of the transactions contemplated by this Agreement shall have been duly and validly taken and all necessary consents, approvals or authorizations of any governmental or regulatory authority or other third party required to be obtained by the Company or Lender shall have been obtained in form and substance reasonably satisfactory to Lender.

 

 
3

 

EXECUTION VERSION

 

6.  Termination. This Agreement may be terminated no later than the Closing:

 

(a) At the option of any party if any other party has materially breached a term of this Agreement and has not cured such breach within five (5) days after notice of such breach; or

 

(b) At the option of any party if any competent regulatory authority shall have issued an order making illegal or otherwise restricting, preventing, prohibiting or refusing to approve the transactions contemplated hereby, and such order shall have become final and non-appealable.

 

7.  Miscellaneous.

 

(a) Further Instruments . The parties agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.

 

(b) Notice . All notices required or permitted hereunder shall be in writing and shall be deemed effectively given (i) upon personal delivery, (ii) when sent by confirmed facsimile, if sent during normal business hours of recipient, or if not, then on the next business day, (iii) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt, or (iv) when sent by confirmed email if sent during normal business hours of recipient, or if not, then on the next business day. All communications shall be sent to the party to be notified at the address set forth on the signature pages hereof, or at such other address as such party may designate by giving ten (10) days’ advance written notice to the other party hereto.

 

(c) Successors and Assigns . This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to the restrictions on transfer herein set forth, be binding upon Lender, Lender’s heirs, executors, administrators, successors and assigns.

 

(d) Applicable Law; Entire Agreement; Amendments . This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, entered into and to be performed entirely within Delaware, and constitutes the entire agreement of the parties with respect to the subject matter hereof superseding all prior written or oral agreements, and no amendment or addition hereto shall be deemed effective unless agreed to in writing by the parties hereto.

 

(e) Severability . If any provision of this Agreement is held by a court to be invalid, void or unenforceable, the remaining provisions shall nevertheless continue in full force and effect without being impaired or invalidated in any way and shall be construed in accordance with the purposes and tenor and effect of this Agreement.

 

(f) Counterparts . This Agreement may be executed by facsimile or other electronic signature, in counterparts, which, when taken together, shall constitute one and the same original.

 

[SIGNATURE PAGE FOLLOW]

 

 
4

 

EXECUTION VERSION

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

 

  COMPANY  
 
  FUSE MEDICAL, INC., a Delaware corporation  
   
By: /s/ Alan Meeker  
  Name: Alan Meeker  
  Title: Chief Executive Officer  

 

 
 

Address:

   

 

 

 

 

 

LENDER :

 

 

WORLD HEALTH INDUSTRIES, INC., a Missouri corporation

   
By: /s/ Mitchell Chad Barrett
Name: Mitchell Chad Barrett
Title: CEO

Address:

 
 
 

WHIG, LLC, a Mississippi limited liability company

   
By: /s/ Mitchell Chad Barrett
Name: Mitchell Chad Barrett
Title: Manager
 

Address:

 

 

 

 

[SIGNATURE PAGE TO DEBT CONVERSION AGREEMENT]

 

 

5


EXHIBIT 10.5

 

EXECUTION VERSION

 

DEBT CONVERSION AGREEMENT

 

THIS DEBT CONVERSION AGREEMENT (this “ Agreement ”) is made and entered into as of December 31, 2014, by and between Fuse Medical, Inc., a Delaware corporation (the “ Company ”), and Cooks Bridge, LLC, a Delaware limited liability company (“ Lender ”).

 

RECITALS

 

A. The Company and Lender are parties to a Debt Assumption and Release Agreement, dated as of the date hereof (the “ Debt Assumption Agreement ”), pursuant to which the Company assumed $466,933.27 of principal and $18,328.44 of accrued interest owed to Lender (the “ Outstanding Debt ”) and the parties agreed to enter into this Agreement to retire the Outstanding Debt.

 

B. The parties to this Agreement have agreed to convert the Outstanding Debt into shares of the Company’s common stock as herein described, according to the terms and subject to the conditions hereinafter set forth.

 

NOW, THEREFORE, in consideration for the mutual promises and covenants set forth herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows:

 

1.  Debt Conversion.

 

(a) Lender agrees, subject to the conditions set forth herein, to convert the full amount of the Outstanding Debt into 466,598 shares of the Company’s common stock (the “ Conversion Shares ”) at a conversion price of $1.04 per share (the “ Conversion Price ”).

 

(b) Subject to the terms and conditions of this Agreement, the consummation of the transaction contemplated by this Agreement shall take place at a closing (the “ Closing ”) to be held at 10:00 a.m., local time, on date set by the Company, but no later than December 31, 2014, at the offices of the Company, or at such other time, date or place as the parties may agree upon in writing. At the Closing, Lender shall deliver a certificate of an officer acknowledging the retirement of the Outstanding Debt and the Company shall deliver a certificate evidencing ownership of the Conversion Shares and which shall include the restrictive legend.

 

2.  Legends. All certificates representing any shares subject to the provisions of this Agreement shall have endorsed thereon the following legends:

 

(a)  “THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES. THE SALE IS MADE IN ACCORDANCE WITH RULE 144 UNDER THE ACT, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE SECURITIES REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT.”

 

 
1

 

EXECUTION VERSION

 

(b) Any other legend required to be placed thereon under applicable state securities laws.

 

3.  Representations and Warranties. In connection with the proposed conversion, Lender hereby agrees, represents and warrants as follows:

 

(a) Lender has full legal power and capacity to execute and deliver this Agreement and to perform its obligations hereunder. All acts required to be taken by Lender to enter into this Agreement and to carry out the transaction contemplated hereby have been properly taken; and this Agreement constitutes a legal, valid and binding obligation of Lender enforceable in accordance with its terms.

 

(b) Lender is receiving the Conversion Shares solely for Lender’s own account for investment and not with a view to, or for resale in connection with, any distribution thereof within the meaning of the Securities Act. Lender has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Company’s securities.

 

(c) Lender has been given an opportunity to ask questions and receive answers from the officers and directors of the Company and to obtain additional information from the Company. Lender realizes that acceptance of the Conversion Shares at the Conversion Price is an investment in the Company, which is a highly speculative investment, and Lender is able, without impairing Lender’s financial condition, to hold the Conversion Shares for an indefinite period of time and to suffer a complete loss of Lender’s investment.

 

(d) Lender is relying solely on the representations and warranties contained herein in making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, and no oral representations or warranties of any kind have been made by the Company or its officers, directors, employees or agents to Lender.

 

(e) The Company has disclosed to Lender that:

 

(i) The Conversion Shares have not been registered under the Securities Act and the Conversion Shares must be held indefinitely unless a transfer is subsequently registered under the Securities Act, or an exemption from such registration is available, and that the Company is under no obligation to register the Conversion Shares;

 

(ii) The Company will make a notation in its records of the aforementioned restrictions on transfer and legends.

 

(f) Lender has sought such independent legal, tax and accounting advice and counsel as it has deemed necessary and appropriate and Lender is relying on the advice and counsel of his own legal, tax and accounting advisors.

 

 
2

 

EXECUTION VERSION

 

(g) Without in any way limiting Lender’s representations and warranties set forth above, Lender further agrees that Lender shall in no event make any disposition of all or any portion of the Conversion Shares which Lender is acquiring unless and until:

 

(i) There is then in effect a registration statement under the Securities Act (a “ Registration Statement ”) covering such proposed disposition and such disposition is made in accordance with said Registration Statement; or

 

(ii) Lender shall have notified the Company of the proposed disposition and the Company agrees that such disposition is exempt from the registration requirements of applicable state and federal securities laws.

 

4.  Transfers in Violation of Agreement. The Company shall not be required to (i) transfer on its books any Conversion Shares of the Company which shall have been sold or transferred in violation of any of the provisions set forth in this Agreement, or (ii) treat as owner of such shares or to accord the right to vote as such owner or to pay dividends to any transferee to whom such shares shall have been so transferred.

 

5.  Conditions.

 

(a) The obligations of the Company to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment of the following conditions:

 

(i) The representations and warranties of Lender set forth in Section 3  hereof shall be true and correct on and as of the Closing date.

 

(ii) All proceedings to be taken by Lender in connection with the consummation of the transactions contemplated by this Agreement shall have been duly and validly taken and all necessary consents, approvals or authorizations of any governmental or regulatory authority or other third party required to be obtained by the Company or Lender shall have been obtained in form and substance reasonably satisfactory to the Company.

 

(iii) Lender has delivered to the Company a certificate acknowledging the conversion of the Outstanding Debt and that there are no other obligations of the Company to Lender.

 

(b) The obligations of Lender to consummate the transaction contemplated by this Agreement shall be subject to the fulfillment of the following conditions:

 

(i) The representations and warranties of the Company set forth herein shall be true and correct on and as of the Closing date.

 

(ii) All proceedings, corporate or otherwise, to be taken by the Company in connection with the consummation of the transactions contemplated by this Agreement shall have been duly and validly taken and all necessary consents, approvals or authorizations of any governmental or regulatory authority or other third party required to be obtained by the Company or Lender shall have been obtained in form and substance reasonably satisfactory to Lender.

 

 
3

 

EXECUTION VERSION

 

6.  Termination. This Agreement may be terminated no later than the Closing:

 

(a) At the option of any party if any other party has materially breached a term of this Agreement and has not cured such breach within five (5) days after notice of such breach; or

 

(b) At the option of any party if any competent regulatory authority shall have issued an order making illegal or otherwise restricting, preventing, prohibiting or refusing to approve the transactions contemplated hereby, and such order shall have become final and non-appealable.

 

7.  Miscellaneous.

 

(a) Further Instruments . The parties agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.

 

(b) Notice . All notices required or permitted hereunder shall be in writing and shall be deemed effectively given (i) upon personal delivery, (ii) when sent by confirmed facsimile, if sent during normal business hours of recipient, or if not, then on the next business day, (iii) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt, or (iv) when sent by confirmed email if sent during normal business hours of recipient, or if not, then on the next business day. All communications shall be sent to the party to be notified at the address set forth on the signature pages hereof, or at such other address as such party may designate by giving ten (10) days’ advance written notice to the other party hereto.

 

(c) Successors and Assigns . This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to the restrictions on transfer herein set forth, be binding upon Lender, Lender’s heirs, executors, administrators, successors and assigns.

 

(d) Applicable Law; Entire Agreement; Amendments . This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, entered into and to be performed entirely within Delaware, and constitutes the entire agreement of the parties with respect to the subject matter hereof superseding all prior written or oral agreements, and no amendment or addition hereto shall be deemed effective unless agreed to in writing by the parties hereto.

 

(e) Severability . If any provision of this Agreement is held by a court to be invalid, void or unenforceable, the remaining provisions shall nevertheless continue in full force and effect without being impaired or invalidated in any way and shall be construed in accordance with the purposes and tenor and effect of this Agreement.

 

(f) Counterparts . This Agreement may be executed by facsimile or other electronic signature, in counterparts, which, when taken together, shall constitute one and the same original.

 

[SIGNATURE PAGE FOLLOW]

 

 
4

 

EXECUTION VERSION

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

 

 

COMPANY

 
   

FUSE MEDICAL, INC., a Delaware corporation

       
By: /s/ Alan Meeker  
  Name: Alan Meeker  
  Title: Chief Executive Officer  
 

Address:

 
       
 
 

LENDER :

 

 

COOKS BRIDGE, LLC, a Delaware limited liability company

 

 
By: /s/ Rusty Shelton
Name: Rusty Shelton

Title:

Manager
   

Address:

 

 

[SIGNATURE PAGE TO DEBT CONVERSION AGREEMENT]

 

 

5


 

EXHIBIT 10.6

 

EXECUTION VERSION

 

DEBT CONVERSION AGREEMENT

 

THIS DEBT CONVERSION AGREEMENT (this “ Agreement ”) is made and entered into as of December 31, 2014, by and between Fuse Medical, Inc., a Delaware corporation (the “ Company ”), and JAR Financing LLC, a Delaware limited liability company (“ Lender ”).

 

RECITALS

 

A. The Company and Lender are parties to a Debt Assumption and Release Agreement, dated as of the date hereof (the “ Debt Assumption Agreement ”), pursuant to which the Company assumed $317,305.10 of principal and $13,318.25 of accrued interest owed to Lender (the “ Outstanding Debt ”) and the parties agreed to enter into this Agreement to retire the Outstanding Debt.

 

B. The parties to this Agreement have agreed to convert the Outstanding Debt into shares of the Company’s common stock as herein described, according to the terms and subject to the conditions hereinafter set forth.

 

NOW, THEREFORE, in consideration for the mutual promises and covenants set forth herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereby agree as follows:

 

1.  Debt Conversion.

 

(a) Lender agrees, subject to the conditions set forth herein, to convert the full amount of the Outstanding Debt into 317,908 shares of the Company’s common stock (the “ Conversion Shares ”) at a conversion price of $1.04 per share (the “ Conversion Price ”).

 

(b) Subject to the terms and conditions of this Agreement, the consummation of the transaction contemplated by this Agreement shall take place at a closing (the “ Closing ”) to be held at 10:00 a.m., local time, on date set by the Company, but no later than December 31, 2014, at the offices of the Company, or at such other time, date or place as the parties may agree upon in writing. At the Closing, Lender shall deliver a certificate of an officer acknowledging the retirement of the Outstanding Debt and the Company shall deliver a certificate evidencing ownership of the Conversion Shares and which shall include the restrictive legend.

 

2.  Legends. All certificates representing any shares subject to the provisions of this Agreement shall have endorsed thereon the following legends:

 

(a)  “THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), AND MAY NOT BE SOLD, TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES. THE SALE IS MADE IN ACCORDANCE WITH RULE 144 UNDER THE ACT, OR THE COMPANY RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE SECURITIES REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE, TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT.”

 

 
1

 

EXECUTION VERSION

 

(b) Any other legend required to be placed thereon under applicable state securities laws.

 

3.  Representations and Warranties. In connection with the proposed conversion, Lender hereby agrees, represents and warrants as follows:

 

(a) Lender has full legal power and capacity to execute and deliver this Agreement and to perform its obligations hereunder. All acts required to be taken by Lender to enter into this Agreement and to carry out the transaction contemplated hereby have been properly taken; and this Agreement constitutes a legal, valid and binding obligation of Lender enforceable in accordance with its terms.

 

(b) Lender is receiving the Conversion Shares solely for Lender’s own account for investment and not with a view to, or for resale in connection with, any distribution thereof within the meaning of the Securities Act. Lender has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Company’s securities.

 

(c) Lender has been given an opportunity to ask questions and receive answers from the officers and directors of the Company and to obtain additional information from the Company. Lender realizes that acceptance of the Conversion Shares at the Conversion Price is an investment in the Company, which is a highly speculative investment, and Lender is able, without impairing Lender’s financial condition, to hold the Conversion Shares for an indefinite period of time and to suffer a complete loss of Lender’s investment.

 

(d) Lender is relying solely on the representations and warranties contained herein in making its decision to enter into this Agreement and to consummate the transactions contemplated hereby, and no oral representations or warranties of any kind have been made by the Company or its officers, directors, employees or agents to Lender.

 

(e) The Company has disclosed to Lender that:

 

(i) The Conversion Shares have not been registered under the Securities Act and the Conversion Shares must be held indefinitely unless a transfer is subsequently registered under the Securities Act, or an exemption from such registration is available, and that the Company is under no obligation to register the Conversion Shares;

 

(ii) The Company will make a notation in its records of the aforementioned restrictions on transfer and legends.

 

(f) Lender has sought such independent legal, tax and accounting advice and counsel as it has deemed necessary and appropriate and Lender is relying on the advice and counsel of his own legal, tax and accounting advisors.

 

 
2

 

EXECUTION VERSION

 

(g) Without in any way limiting Lender’s representations and warranties set forth above, Lender further agrees that Lender shall in no event make any disposition of all or any portion of the Conversion Shares which Lender is acquiring unless and until:

 

(i) There is then in effect a registration statement under the Securities Act (a “ Registration Statement ”) covering such proposed disposition and such disposition is made in accordance with said Registration Statement; or

 

(ii) Lender shall have notified the Company of the proposed disposition and the Company agrees that such disposition is exempt from the registration requirements of applicable state and federal securities laws.

 

4.  Transfers in Violation of Agreement. The Company shall not be required to (i) transfer on its books any Conversion Shares of the Company which shall have been sold or transferred in violation of any of the provisions set forth in this Agreement, or (ii) treat as owner of such shares or to accord the right to vote as such owner or to pay dividends to any transferee to whom such shares shall have been so transferred.

 

5.  Conditions.

 

(a) The obligations of the Company to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment of the following conditions:

 

(i) The representations and warranties of Lender set forth in Section 3  hereof shall be true and correct on and as of the Closing date.

 

(ii) All proceedings to be taken by Lender in connection with the consummation of the transactions contemplated by this Agreement shall have been duly and validly taken and all necessary consents, approvals or authorizations of any governmental or regulatory authority or other third party required to be obtained by the Company or Lender shall have been obtained in form and substance reasonably satisfactory to the Company.

 

(iii) Lender has delivered to the Company a certificate acknowledging the conversion of the Outstanding Debt and that there are no other obligations of the Company to Lender.

 

(b) The obligations of Lender to consummate the transaction contemplated by this Agreement shall be subject to the fulfillment of the following conditions:

 

(i) The representations and warranties of the Company set forth herein shall be true and correct on and as of the Closing date.

 

(ii) All proceedings, corporate or otherwise, to be taken by the Company in connection with the consummation of the transactions contemplated by this Agreement shall have been duly and validly taken and all necessary consents, approvals or authorizations of any governmental or regulatory authority or other third party required to be obtained by the Company or Lender shall have been obtained in form and substance reasonably satisfactory to Lender.

 

 
3

 

EXECUTION VERSION

 

6.  Termination. This Agreement may be terminated no later than the Closing:

 

(a) At the option of any party if any other party has materially breached a term of this Agreement and has not cured such breach within five (5) days after notice of such breach; or

 

(b) At the option of any party if any competent regulatory authority shall have issued an order making illegal or otherwise restricting, preventing, prohibiting or refusing to approve the transactions contemplated hereby, and such order shall have become final and non-appealable.

 

7.  Miscellaneous.

 

(a) Further Instruments . The parties agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement.

 

(b) Notice . All notices required or permitted hereunder shall be in writing and shall be deemed effectively given (i) upon personal delivery, (ii) when sent by confirmed facsimile, if sent during normal business hours of recipient, or if not, then on the next business day, (iii) one (1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt, or (iv) when sent by confirmed email if sent during normal business hours of recipient, or if not, then on the next business day. All communications shall be sent to the party to be notified at the address set forth on the signature pages hereof, or at such other address as such party may designate by giving ten (10) days’ advance written notice to the other party hereto.

 

(c) Successors and Assigns . This Agreement shall inure to the benefit of the successors and assigns of the Company and, subject to the restrictions on transfer herein set forth, be binding upon Lender, Lender’s heirs, executors, administrators, successors and assigns.

 

(d) Applicable Law; Entire Agreement; Amendments . This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, entered into and to be performed entirely within Delaware, and constitutes the entire agreement of the parties with respect to the subject matter hereof superseding all prior written or oral agreements, and no amendment or addition hereto shall be deemed effective unless agreed to in writing by the parties hereto.

 

(e) Severability . If any provision of this Agreement is held by a court to be invalid, void or unenforceable, the remaining provisions shall nevertheless continue in full force and effect without being impaired or invalidated in any way and shall be construed in accordance with the purposes and tenor and effect of this Agreement.

 

(f) Counterparts . This Agreement may be executed by facsimile or other electronic signature, in counterparts, which, when taken together, shall constitute one and the same original.

 

[SIGNATURE PAGE FOLLOW]

 

 
4

 

EXECUTION VERSION

 

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first above written.

 

  COMPANY  
 

FUSE MEDICAL, INC., a Delaware corporation

       
By: /s/ Alan Meeker  
  Name: Alan Meeker  
  Title: Chief Executive Officer  
       

Address:

 
   
 
 

LENDER :

 

 

JAR Financing LLC, a Delaware limited liability company

 

 

By:

/s/ Rusty Shelton

Name:

Rusty Shelton

Title:

Manager
 

Address:

 

 

 

 

5